Bonk Inc. (BNKK) Dividend Safety Gauge & 10-Year DRIP Compounder

$1.18 -2.48% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.17

Bonk Inc. (BNKK) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $9.4M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BNKK Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BNKK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-02, Bonk Inc. (NASDAQ: BNKK) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $1.18 (-2.48% 1D, market cap $9.4M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 1011 tracked Consumer Discretionary issuers, BNKK ranks #816 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BNKK compare to BYAH and CABR in the Consumer Discretionary sector?
▼

Within the Consumer Discretionary sector (Package Goods/Cosmetics), BNKK carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 58.5%, and ROIC of -35.0%. By comparison, BYAH (Park Ha Biological Technology Co. Ltd. (Class A)) holds a D grade (45/100 RQD, P/E N/A, ROIC —, cap $7.9M) and CABR (Caring Brands Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $11.2M). Among the 5-stock peer group, UG leads on earnings multiple (14.5x) while UG leads on capital efficiency (17.8% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BNKK?
▼

Per BNKK's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001760903), Bonk Inc. generated $2.1M in revenue (+201.6% YoY), -$68.2M in net income, and -$25.3M in free cash flow against $41.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.17 (-0.64%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.5% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • D-
025507510035
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D
Cash (7)Whales (5)SEC (11)Macro (7)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-10.2% Base Target
$9 Bull$1 Base$1 Bear
📬 FREE BNKK RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BNKK)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (35/100 Composite)
🔍 WHY BNKK SCORES 35/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (31% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Cash Engine Quality+7/20 pts (20% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 58.5% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
43
Grade D$1.34-13.4% Next Q
Q2 (-2Q)
40
Grade D$1.16-5.2% Next Q
Q3 (-1Q)
38
Grade E$1.10+7.3% Next Q
Current
35
Grade D-$1.18-8.5% Hist 90D α
Trajectory: D (43) → D- (35)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BNKK Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BNKK currently carries a cautious 35/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.36) and Max Pain ($1.24) forces dealer call-delta covering toward $9.33.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BNKK• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “BNKK Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
CASH DIVIDEND + BUYBACK YIELD
1.8% Total Yield
0% Cash ($0.00/yr) + 1.8% Buybacks
PAYOUT SAFETY SPEEDOMETER
74/100 • REINVESTING IN GROWTH + BUYBACKS
FREE CASH FLOW PAYOUT RATIO
0% (100% Reinvested)
Retains cash flow for R&D and share repurchases
INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (16.3% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $45,269

Est. Year-10 Shareholder Yield: $815/yr
$11.6K
Yr 1
$13.5K
Yr 2
$15.7K
Yr 3
$18.3K
Yr 4
$21.3K
Yr 5
$24.7K
Yr 6
$28.8K
Yr 7
$33.5K
Yr 8
$38.9K
Yr 9
$45.3K
Yr 10
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BNKK)

  • ✓Walkthrough of BNKK's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
BNKK // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -53.36%📐 HORIZONTAL RANGE
2026-11-02O $1.21H $1.21L $1.18C $1.18VOL 34.9K
RES: $2.42SUP: $0.90SMA50: $1.36SMA200: $2.13
$9.07$6.86$4.64$2.43$0.21RES $2.42SUP $0.90$1.182026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BNKK Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BNKK today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BNKK. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BNKK today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BNKK)

Consumer Discretionary Rank #816 of 1011 ⚔️ BYAH vs BNKK Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (BNKK vs. BYAH, CABR, YCBD, UG)

Industry: Package Goods/Cosmetics (23 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Bonk Inc. (BNKK) ranks #816 by composite RQD confidence (35/100, grade D-) and #931 by equity capitalization ($9.4M). Within this direct 5-issuer industry benchmark cohort, UG leads on earnings valuation at 14.5x trailing P/E, while UG leads on capital efficiency and profitability with 17.8% ROIC and — gross margin. UG currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with BNKK at 35/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
BNKK ACTIVE
Bonk Inc.
D- 35/100 — 58.5% -35.0% -2.48% $9.4M Benchmark Subject
BYAH
Park Ha Biological Technology Co. Ltd. (Class A)
D 45/100 — 94.4% — +1.71% $7.9M /byah-vs-bnkk →
CABR
Caring Brands Inc.
D- 37/100 — 55.6% -35.0% -4.46% $11.2M /cabr-vs-bnkk →
YCBD
cbdMD Inc.
D- 37/100 — 62.4% -30.4% +4.56% $4.3M /ycbd-vs-bnkk →
UG
United-Guardian Inc.
C- 61/100 14.5x — 17.8% -1.19% $30.6M /ug-vs-bnkk →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001760903

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Bonk Inc. (BNKK) reported GAAP revenue of $2.1M (+201.6% vs. FY2024 revenue of $702.0K , and +944.7% cumulative change since FY2023) , GAAP net income of -$68.2M, operating cash flow of -$25.3M, and free cash flow of -$25.3M (-39.1% YoY). On the balance sheet, BNKK closed FY2025 with $41.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $2.1M -$68.2M -$25.3M -$25.3M $41.0M —
FY2024 (FY) 2024-12-31 $702.0K -$49.4M -$18.1M -$18.2M $7.3M —
FY2023 (FY) 2023-12-31 $202.7K -$15.1M -$10.5M -$10.5M — —

3. BNKK Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BNKK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Bonk Inc. (NASDAQ: BNKK) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $1.18 (-2.48% 1D, market cap $9.4M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 1011 tracked Consumer Discretionary issuers, BNKK ranks #816 in composite RQD confidence.

How does BNKK compare to BYAH and CABR in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Package Goods/Cosmetics), BNKK carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 58.5%, and ROIC of -35.0%. By comparison, BYAH (Park Ha Biological Technology Co. Ltd. (Class A)) holds a D grade (45/100 RQD, P/E N/A, ROIC —, cap $7.9M) and CABR (Caring Brands Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $11.2M). Among the 5-stock peer group, UG leads on earnings multiple (14.5x) while UG leads on capital efficiency (17.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BNKK?

Per BNKK's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001760903), Bonk Inc. generated $2.1M in revenue (+201.6% YoY), -$68.2M in net income, and -$25.3M in free cash flow against $41.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BNKK trading relative to its 50-day, 200-day, and 52-week technical levels?

BNKK last traded at $1.18 (-2.48% on volume of 34,872 shares), positioning the stock -13.24% below its 50-day simple moving average ($1.36) and -44.60% below its 200-day simple moving average ($2.13). Across its 52-week range of $0.90 to $8.89, BNKK sits at the 3.5% percentile with a 14-day RSI of 45.3 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.03 to $1.33).

BNKK Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does BNKK pay a dividend and is it safe?

Bonk Inc. (BNKK) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%